The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands.
作者： Eldad Tzahar , Yosef Yarden
DOI: 10.1016/S0304-419X(97)00032-2
关键词: Receptor tyrosine kinase 、 Chemistry 、 Platelet-derived growth factor receptor 、 Neuregulin 、 Growth factor receptor 、 Insulin-like growth factor 1 receptor 、 ErbB 、 ROR1 、 Signal transduction 、 Cancer research
摘要: Extensive clinical and biochemical evidence implicates ErbB-2, a transmembrane tyrosine kinase related to growth factor receptors, in the development, metastasis, and resistance to …
elsevier.com
sci-hub.se 参考文章(117)
Ilana Stancovski, Michael Sela, Yosef Yarden, Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase Cancer treatment and research. ,vol. 71, pp. 161- 191 ,(1994) , 10.1007/978-1-4615-2592-9_9
E. Peles, R. Ben-Levy, E. Tzahar, N. Liu, D. Wen, Y. Yarden, Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. The EMBO Journal. ,vol. 12, pp. 961- 971 ,(1993) , 10.1002/J.1460-2075.1993.TB05737.X
Brammar Wj, Walker Ra, Varley Jm, Whittaker Jl, Swallow Je, Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene. ,vol. 1, pp. 423- 430 ,(1987)
Buchler M, Korc M, Kobrin Ms, Yamanaka Y, Friess H, Beger Hg, Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Research. ,vol. 13, pp. 565- 569 ,(1993)
Spaventi S, Pavelic K, Banjac Z, Pavelic J, Evidence for a role of EGF receptor in the progression of human lung carcinoma Anticancer Research. ,vol. 13, pp. 1133- 1137 ,(1993)
E. Peles, R.B. Levy, E. Or, A. Ullrich, Y. Yarden, Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma. The EMBO Journal. ,vol. 10, pp. 2077- 2086 ,(1991) , 10.1002/J.1460-2075.1991.TB07739.X
M D Pegram, R J Pietras, S B Howell, V R Chazin, B M Fendly, D J Slamon, Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene. ,vol. 9, pp. 1829- 1838 ,(1994)
DJ Riese 2nd, Yamilee Bermingham, TM Van Raaij, Sharon Buckley, Greogry D Plowman, David F Stern, Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene. ,vol. 12, pp. 345- 353 ,(1996)
S.A. Prigent, W.J. Gullick, Identification of c-erbB-3 binding sites for phosphatidylinositol 3'-kinase and SHC using an EGF receptor/c-erbB-3 chimera. The EMBO Journal. ,vol. 13, pp. 2831- 2841 ,(1994) , 10.1002/J.1460-2075.1994.TB06577.X
Y. Suda, S. Aizawa, Y. Furuta, T. Yagi, Y. Ikawa, K. Saitoh, Y. Yamada, K. Toyoshima, T. Yamamoto, Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659----Glu659). The EMBO Journal. ,vol. 9, pp. 181- 190 ,(1990) , 10.1002/J.1460-2075.1990.TB08094.X